Albitride Tablet
Ranitidine Hydrochloride 168mg · Tripotassium Bismuth Dicitrate 200mg +1 more
Prescription medication · Combination
Cheil Pharmaceutical Co., Ltd.
MFDS item code 201506828 · Approved 2015.09.30
This product's status changed to Approval withdrawn on 2025.07.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (ulcers, gastritis, reflux esophagitis, etc.); prevention of Mendelson's syndrome
This medication is used to treat gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. Additionally, it is administered to prevent Mendelson's syndrome during anesthesia before surgery and is also effective for treating ulcers that may occur after surgery and gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). This medicine regulates gastric acid secretion, protecting the gastric mucosa and aiding in ulcer healing. Therefore, it is widely used for symptom improvement and treatment of gastrointestinal diseases.
○ Adults The usual dose is 1 tablet orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 1 tablet twice daily or 2 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or for prevention of gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 1 tablet once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 1 tablet twice daily or 2 tablets once daily at bedtime for 8 weeks. For patients with severe reflux esophagitis, the dose may be increased to 2 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 1 tablet 3 times daily and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 1 tablet twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 1 tablet 2 hours before induction of anesthesia. In this case, it is also preferable to administer 1 tablet on the night before surgery.
This medication should not be used in patients undergoing dialysis or those with kidney function problems. In addition, it should not be administered to individuals who have had allergic reactions to this medication or its components, patients with a history of acute porphyria, those who have undergone upper gastrointestinal tract surgery, pregnant women, women who may become pregnant, premature infants, and newborns on potassium-restricted diets. Patients with liver function impairment or a history of drug allergies, the elderly, and those with a past history of kidney impairment should use this medication with caution. Patients taking non-steroidal anti-inflammatory drugs, especially the elderly or those with a history of peptic ulcers, should be regularly monitored. This medication may mask symptoms of gastric cancer; therefore, patients with gastric ulcers or those who develop new or altered digestive symptoms over middle age should undergo procedures to rule out malignant conditions before administration. Patients with Helicobacter pylori gastric or duodenal ulcers should undergo bacterial eradication therapy. Special attention is required for severely ill patients in the intensive care unit, those with hypophosphatemia, or those with swallowing difficulties. Rarely, during the use of this medication, severe allergic reactions, blood-related abnormalities, liver dysfunction, cardiac arrhythmias, gastrointestinal symptoms, and neuropsychiatric symptoms may occur, so any unusual symptoms should be reported to medical personnel immediately. In particular, if dizziness or drowsiness occurs, it is advisable to avoid driving or operating hazardous machinery. It is recommended not to use this medication for extended periods, and if there is no therapeutic effect, it should be switched to another medication. Moreover, this medication may interact with other drugs, so it is essential to inform medical personnel of any other medications being taken. It is safest for pregnant or potentially pregnant women, as well as nursing mothers, to avoid using this medication. Children should not be given this medication as its safety and efficacy have not been adequately established in this population. In cases of overdose, emergency measures such as vomiting or gastric lavage may be needed, and blood dialysis may be used to remove the drug if necessary. Finally, this medication reduces gastric acid secretion, which may promote bacterial growth in the gastrointestinal tract, and prolonged use may affect eye health, necessitating an ophthalmological examination.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius. This helps to prolong the drug's efficacy.
Green oblong film-coated triple tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg · Tripotassium Bismuth Dicitrate 200mg +1 more
Prescription medication · Combination
Cheil Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.